IQOS and ZYN power PM's smoke-free growth in Q2, now accounting for more than 40% of revenues and gross profit.

Philip Morris International Inc.’s shares fell after shipments of its Zyn nicotine pouches accelerated by less than analysts ...

Traditional cigarette sales volumes continue to fall, but the tobacco giant is compensating with its newer nicotine products.

Philip Morris' second quarter results for 2025 met non-GAAP earnings expectations but fell short of Wall Street’s revenue ...

Zyn launched in the U.S. in 2014, but sales have exploded in the past year, generating $1.8 billion as shipments accelerated year-over-year by over 60%.

Philip Morris International Inc. (NYSE:PM) is one of the defensive stocks billionaires are buying amid US trade tariff ...

The Brief FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free ...

Philip Morris shares dropped 7% after Q2 revenue missed expectations due to weaker cigarette sales and lower-than-forecast ...

The manufacturers of Zyn nicotine pouches will be paying $1.2 million for violating D.C.’s 2022 ban on flavored tobacco and nicotine products, Attorney General Brian L. Schwalb announced on Friday.